ALK-Positive Non-Small Cell Lung Cancer Overview

Save information for later
Sign Up

Learn About ALK-Positive Non-Small Cell Lung Cancer

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top ALK-Positive Non-Small Cell Lung Cancer Local Doctors?
Hematology Oncology | Hematology | Oncology
Hematology Oncology | Hematology | Oncology

University Of Miami

1475 Nw 12th Ave, 
Miami, FL 
 2.3 mi
Accepting New Patients
Offers Telehealth

Estelamari Rodriguez is a Hematologist Oncology specialist and a Hematologist in Miami, Florida. Dr. Rodriguez and is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are Squamous Cell Lung Carcinoma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Bone Marrow Aspiration. Dr. Rodriguez is currently accepting new patients.

Thoracic Surgery | General Surgery
Thoracic Surgery | General Surgery

University Of Miami

1611 Nw 12 Ave, 
Miami, FL 
 2.5 mi
Accepting New Patients
Offers Telehealth

Dao Nguyen is a Thoracic Surgeon and a General Surgeon in Miami, Florida. Dr. Nguyen and is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Lung Adenocarcinoma, Thymectomy, and Endoscopy. Dr. Nguyen is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More

University Of Miami

1611 Nw 12 Th Ave, 
Miami, FL 
 2.5 mi
Accepting New Patients
Offers Telehealth

Gilberto Lopes is an Oncologist in Miami, Florida. Dr. Lopes and is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, and Colorectal Cancer. Dr. Lopes is currently accepting new patients.

What are the latest ALK-Positive Non-Small Cell Lung Cancer Clinical Trials?
A Real-World Study to Evaluate the Effectiveness and Safety of Brigatinib in First Line in Patients With ALK Positive Locally Advanced or Metastatic NSCLC in China: An Ambispective, Non-interventional, Observational, Multi-center Study.

Summary: The main aim of this study is to learn about the time between the start and stop of treatment with brigatinib in Chinese participants with non-small-cell lung cancer (NSCLC) and who have been positively diagnosed with having the anaplastic lymphoma kinase (ALK) gene. Other study aims are to learn about the progression of NSCLC and participants' response to treatment with brigatinib.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Phase I Study of Gilteritinib for ALK Positive Non-Small Cell Lung Cancer

Summary: This phase I trial is studying the safety, side effects, and best dose of gilteritinib in treating patients with stage IV ALK positive non-small cell lung cancer (NSCLC) who have progressed on other treatments. While there are many approved targeted drugs for ALK NSCLC, resistance to these drugs frequently occur. Giltertinib is a drug that is already FDA approved for the treatment of a specific ty...